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Background/aim: The aim of this study was to investigate cytomorphological and cytopathological changes in oral exfoliated smears
collected from immunosuppressed patients with Behçet’s disease (BD) using stereological methods.
Materials and methods: For cytomorphometric analysis, mucosal cell smears were obtained from the buccal mucosa and the floor of
the mouths of BD patients treated with immunosuppressive drugs and from healthy volunteers. All mucosal smears from the patients
and the healthy volunteers were stained using the Papanicolaou method and examined cytopathologically under light microscopy and
cytomorphologically via the stereological nucleator method.
Results: The cytomorphological analysis revealed 3 types of mucosal cells, with numbers of particularly pink cells lower in the aphthous
areas of the patients with BD compared to the healthy controls (P < 0.05). The nuclear volumes (NVs) and cytoplasmic volume (CVs)
were significantly higher in the BD patients (P < 0.05), but the NV/CV ratio was higher only in the drug-use patient groups (P > 0.05).
There was lower apoptotic activity in the nondrug-use patients with BD and in the immunosuppressive-taking BD patients.
Conclusion: The findings suggest that quantifiably morphological and morphometric changes in oral mucosa can be detected by
stereological techniques. Changes in these parameters may indicate malignant transformation in the oral mucosa.
Key words: Behçet’s disease, oral cytology, stereology, quantitative cytomorphology

1. Introduction
Behçet’s disease (BD) is an inflammatory disorder
characterized by recurrent oral ulcers, genital ulcers, and
skin lesions. The etiology of BD is unknown, and a viral
ethology has not been confirmed up to now. The disease
was first described in 1937 by a Turkish dermatologist,
Hulusi Behçet, in 3 Turkish patients with oral and genital
ulcerations and hypopyon uveitis (1). BD seriously affects
all organs of the body, depending on the system involved
(2,3), and it has a high prevalence along the ancient Silk Road
countries, including Turkey (4). Recently, many studies
have focused on the pathogenesis and clinical findings of
BD (1–5). The diagnosis of BD is based on oral and genital
ulcers, uveitis, and skin lesions. In the treatment of BD,
topical and systemic corticosteroids are commonly used as
antiinflammatory agents. Controlled studies of the use of
* Correspondence: ademkara_36@hotmail.com

such agents to treat BD are lacking, but their long-term
use is limited as a result of significant side effects, which
requires the simultaneous use of other immunosuppressive
drugs, such as calcineurin inhibitors (cyclosporine and
tacrolimus), colchicine, azathioprine, interferon alpha,
thalidomide, and pentoxifylline (1,5,6). Some studies have
reported the effects of immunosuppressive drugs on the
oral mucosa cells (7,8). Such effects may be dosage-related,
with gingival squamous cell carcinomas most frequently
reported (9,10).
Diagnoses of oral cancers include incisional
or excisional biopsy of lesions in oral mucosa, and
histopathologic analysis of biopsied material. Oral
exfoliative cytology has been used as a diagnostic method
in the diagnosis of precancerous and cancerous cells
(8). It is a simple method for the morphological and
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cytological assessment of exfoliated cells from the oral
mucosa (11). It is also a cheap and easy procedure for
the diagnosis of lesions in oral mucosal smears and can
determine cytomorphometric alterations at an early stage
(12–14). The higher frequency of premalignant exfoliated
cells from patients taking immunosuppressive drugs has
been observed in previous studies (8–10), indicating
the changing of nuclear and cytoplasmic volumes as an
indicator for the risk of oral squamous cancer.
In the assessment of exfoliative cytology, quantitative
techniques are more objective and accurate and are based
on an evaluation of quantitative values, such as variations
in the size of the nucleus and the cytoplasm, and changes
in the nucleus/cytoplasm ratio may enhance the diagnostic
sensitivity of many diseases (8,15). Stereology is one of
the most reliable methods of making a morphometric
assessment. Stereological methods are based on
fundamental principles of geometry and statistics and can
be applied to morphometric analysis of many different
materials or tissues (8).
Disturbances in cellular homeostasis often trigger
programmed cell death (16). It was suggested that
degenerative alterations in oral epithelium cells are
indicative of apoptosis (karyorrhexis, pyknosis, and
condensed chromatin) (17,18). As well as the micronucleus,
nuclear alterations are indicative of apoptosis (19–22).

The aim of the present study was to investigate
histopathological and quantitative cytological changes of
oral mucosa cells collected from patients with BD who were
taking immunosuppressive drugs. Cytomorphological and
cytopathological alterations were compared in BD patients
taking immunosuppressive drugs and in healthy control
subjects to diagnose oral cancer at an early stage due to
long-term immunosuppressive drug usage.
2. Materials and methods
The study consisted of 38 patients (17 women and 21 men)
with BD and 21 healthy volunteers (9 women and 12 men).
The ages of the volunteers and the patients ranged from 31 to
58 years. The characteristics of the study group are presented
in Table 1. Mucosal smears were obtained from patients
with BD from the Department of Dermatology and the
Department of Ophthalmology of the Faculty of Medicine,
Atatürk University, over a 2-year period. Healthy volunteers
were selected from the Department of Oral Diagnosis and
Radiology in the Faculty of Dentistry, Atatürk University.
All procedures followed the tenets of the Declaration of
Helsinki. Written informed consent was obtained, and a
form was completed detailing the patients’ name, age, sex,
and relevant medical history. Patients with anemia, diabetes
mellitus, radiotherapy, alcohol consumption, or a history of
smoking were not included in the study.

Table 1. Cytomorphometric volumetric analysis of exfoliative cytology by groups: stained smears’ nucleus volume, cytoplasm volume,
and ratio of nucleus and cytoplasm volumes.
Groups

Number of
patients

Nucleus volume
(NV, µm3)

Cytoplasm volume
(CV, µm3)

Nucleus/cytoplasm
(NC/CV) ratio

Healthy controls’ oral mucosa

21

376.34 ± 31.93a

77,176.69 ± 8990.34a

0.00510 ± 0.0003a

Nondrug-use BD patients’
aphthous areas

14

482.168 ± 47.83b

98,189.21 ± 11,037.73b

0.00517 ± 0.0011a

Nondrug-use BD patients’ oral
mucosa

14

277.598 ± 51.72a

72,033.13 ± 16,831.07a

0.00383 ± 0.0006a

Colchicine-use BD patients’
aphthous areas

15

628.67 ± 34.43b

78,566.04 ± 2673.32a

0.00753 ± 0.0022b

Colchicine-use BD patients’ oral
mucosa

15

416.07 ± 28.05a

67,000.28 ± 5899.17c

0.00638 ± 0.0047b

Colchicine + cyclosporine A-use
BD patients’ aphthous areas

9

479.92 ± 55.72b

90,355.22 ± 6522.74b

0.00692 ± 0.0016b

Colchicine + cyclosporine A-use
BD patients’ oral mucosa

9

348.87 ± 94.17a

72,641.22 ± 4967.45ac

0.00514 ± 0.0001a

Values are expressed as means ± standard deviations.
abc
: Different superscripted letters in the same column indicate significant differences between groups with analysis of variance and
Duncan’s post hoc test (P < 0.05).
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The patients were divided into the following groups:
healthy control, nondrug-use BD patients, colchicineuse BD patients, and colchicine + cyclosporine A-use BD
patients. All smears were taken from patients’ oral mucosa
and oral aphthous areas.
2.1. Specimen preparation
The subjects were instructed to gargle with normal saline.
The oral mucosa was dried with a gauze swab to remove
surface debris and excess saliva. Smears were obtained
from both aphthous and nonaphthous areas of the mouth
or tongue of the BD patients using a cytobrush and
transferred to clean dry glass slides. The same procedure
was used to obtain smears from the controls. The slides
were then immediately sprayed with a commercial fixative
containing 95% ethyl alcohol and stained using the
Papanicolaou technique (23).
2.2. Cytopathological examination and apoptotic cell
determination
The morphology, cytopathology, and apoptosis of the
stained cells were examined under a light microscope.
The apoptotic analysis protocol used was as suggested in
previous studies (18–20). Apoptotic cells characterized
by karyorrhexis, condensed chromatin, and pyknosis
were scored as apoptotic cells (Figure 1). The apoptotic
cell density was then examined in 20 randomly selected
areas using an approximately 20× objective with an image
analysis program (Kameram SLR, 1.4.1.0, Mikro Sistem
Ltd., Turkey). The apoptotic cells in the stained smears
were microscopically scored. The following scale was used:
+ = 5–25, ++ = 25–50, and +++ = ≥50. The scores of the
smears for each patient were derived semiquantitatively
using light microscopy. They were scored as follows: none
= –, weak = +, moderate = ++, and strong = +++.
2.3. Stereological assessment
The smears were placed on a motor-driven stage attached
to a microscope, and the cells were projected onto the
monitor via a camera at a magnification of 200×. The

cytoplasmic volume (CV) and the nuclear volume (NV)
of smears containing suspect cells from the buccal mucosa
and the aphthae of the floor of the mouth of BD patients
and from the mouth or the tongue of healthy volunteers
were estimated using the nucleator method (Figure 1) (24).
The following formula was used:

4r
V(N) = 3 / n3 ,
where V(N) is the number-weighted volume, l is the length
of intercepts, and n is the number of nucleator estimates.
As mentioned in the literature, there are specific
requirements for obtaining full randomness in the sectionsampling stage while estimating the volume of small
objects by the nucleator method (8,24,25). However, these
did not need to be applied in the current study because
smears were used.
2.4. Statistical analysis
For statistical analysis, differences between the
cytomorphometric values were tested by ANOVA and
Duncan’s post hoc test using SPSS 17.0 (SPSS Inc.,
Chicago, IL, USA). All data were expressed as mean
averages ± standard deviations. P < 0.05 was considered
to be significant.
3. Results
3.1. Cytopathological results
In the stained oral epithelial cell smears, we morphologically
observed 3 types of cells: pink cells, large green cells, and
small green cells. These cells were classified according to
the size and the color of the cellular components. The pink
cells were the most keratinized cells and were located in
the superficial layer of the oral epithelium. The large green
cells were intermediate keratinized cells and were located
in the intermediate layer. The small green cells were
nonkeratinized cells, and they were located in the basal
layer of the epithelium (26).

Figure 1. Illustration of the stereological estimation procedure: A) estimation of cytoplasm volume, B; estimation of nucleus volume
via the nucleator method.
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group. Additionally, volumetric differences were found
among the healthy controls and the BD patients either with
or without immunosuppression in the nucleus, cytoplasm,
and their proportions. We found a significant increase
in the NVs of the aphthous areas and the oral mucosa of
the patient group with and without drug use compared
to the healthy controls (P < 0.05). However, there was no
significant difference in the NVs in the aphthous areas
of the nonimmunosuppressive-taking patients and the
colchicine + cyclosporine A group (P > 0.05). In addition,
the CVs of the aphthous areas of the nondrug-use and
colchicine + cyclosporine A-use patients were higher than
those of the other groups (P < 0.05). The NV/CV ratio was
also higher in the colchicine and colchicine + cyclosporine
groups (P < 0.05). The results of volumetric analysis for all
groups are presented in Table 2.

In the cytopathological examination of the smears
from all the groups, the pink cells were observed more
frequently in the healthy controls, whereas the large and
small green cells were observed more often in the nondruguse patients and occasionally in both the colchicine and
cyclosporine groups. The distributions of the cell types are
listed in Table 2 and Figure 2.
3.2. Apoptotic cell analysis
The semiquantitative apoptotic assessments according
to degenerative nuclear changes in all the groups are
presented in Table 2. A lower frequency of apoptotic
cells was observed in both the aphthous areas and the
oral mucosa (nonaphthous areas) of the patients with BD
when compared to the healthy controls. The frequency
of apoptotic cells was also higher in the oral mucosa of
the healthy controls than in the aphthous areas of the
immunosuppressive-taking BD patients. The highest
apoptotic cell density was determined in the healthy
control group.
3.3. Stereological results
The stereological examination revealed higher volumes
of nuclei in the aphthous areas of the BD patients
compared to the healthy controls, and the difference was
statistically significant (P < 0.05). However, there was no
significant difference between the NVs of the oral mucosa
of the healthy controls and the BD patients (P > 0.05).
When we compared the CVs among the groups, they
were significantly different in the aphthous areas of BD
patients and in the oral mucosa in the BD patients with
or without immunosuppressive drug administration. The
NV/CV ratios were increased in the aphthous areas and
the increase was statistically significant in the drug-taking

4. Discussion
The present study investigated the exfoliative cytology of
the oral mucosal cells of healthy controls and BD patients
using immunosuppressive drugs. There was a statistically
significant increase in the NVs and the CVs of the BD
patients and healthy controls in the aphthous areas,
nonaphthous areas, and/or oral mucosa. Furthermore,
the NV/CV ratio was higher in the immunosuppressivetreated patients and this difference was statistically
significant. Therefore, it appears that immunosuppressive
treatment in patients with BD can affect the morphology
of oral cells and activate apoptosis, potentially causing
malignant transformation in patients with BD.
The use of immunosuppressive drugs can be associated
with a number of adverse effects in many patients, and
they can increase the risk of many diseases, such as

Table 2. Semiquantitative analysis of cytomorphological cell type and apoptotic cell density by groups.
Groups

Pink cells

Big green cells

Small green cells

Apoptotic cell
density

Healthy controls’ oral mucosa

+++

–

–

+++

Nondrug-use BD patients’ aphthous areas +

+++

++

+

Nondrug-use BD patients’ oral mucosa

++

+

–

+

Colchicine-use BD patients’ aphthous
areas

+

++

++

+

Colchicine-use BD patients’ oral mucosa

++

+

–

++

Colchicine + cyclosporine A-use BD
patients’ aphthous areas

+

+

+

+

Colchicine + cyclosporine A-use BD
patients’ oral mucosa

++

–

–

++

Cells densities were estimated as follows: none = –, rare = +, weak = ++, moderate = +++, strong = ++++.
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Figure 2. Exfoliated mucosal cells: normal mucosal cell (A), condensed chromatin (B), karyorrhexis (C), and pyknosis (D), with
Papanicolaou staining.

Figure 3. Illustration of exfoliative cells of oral mucosa stained smears: A) pink cell, B) large green cell, C) small green cell, with
Papanicolaou staining.

hypertension, cancer (27,28), renal impairment (29–31),
and skin atrophy (32,33). A number of studies have
reported that immunosuppressive drugs (colchicine,
cyclosporine, and infliximab) caused some pathologies,
including aortic involvement, lower serum creatinine,
and nephrotoxicity, in patients with BD (30,31,34). BD
patients may be at a higher risk of such diseases because of

longer periods of drug administration. The present study
suggests that long-term immunosuppressive drug use has
cytopathological and cytomorphometric effects on oral
mucosa cells.
As the induction of apoptosis results in DNA
damage (35,36), we assessed the extent of oral epithelial
cell apoptosis in exfoliated mucosal cells from
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immunosuppressed patients with BD and healthy controls.
The results revealed that the apoptotic cell density in the
oral mucosa of the patients with BD was higher than in
the long-term immunosuppressive drug-taking groups.
In contrast, other studies suggested that apoptotic
activation was lower in the peripheral lymphocytes (37),
oral epithelium (21), and skin lesions of BD patients (38).
The inhibitions of apoptosis in the immunosuppressive
drug-taking groups may be related to the activation of
proinflammatory cytokines, which are suppressed by
immunosuppressive drugs (39).
In the current study, we performed a stereological
analysis of the oral epithelium to determine
malignant transformations associated with long-term
immunosuppressive drug usage in patients with BD. In
the cytomorphometric analysis, we observed a statistically
significant increase in the NVs and CVs of the oral mucosa
cells in the aphthous areas of the immunosuppressivetaking and nondrug-use groups (P < 0.05). Similarly, there
was a significant increase in the mean NV/CV ratio in
smears from the aphthous areas of the drug-use patients
(P < 0.05). A previous study suggested that CVs and NVs
were increased by cell functions and that the cellular CVs
reached a maximum when cells were ready to divide (40).
It was also noted that the increased proliferative capacity

of these cells has a negative impact on cell volumes (40).
Cellular swelling is an important factor for proliferative
changes in the cell cycle (32). In the present study, we
demonstrated that immunosuppressive treatment in the
patients with BD affected the NVs and CVs of oral cells
and that these changes may point to a malignant process
in the cell cycle.
In the current study, we also demonstrated that there
are semiquantitative cytopathological changes in the cells
of patients with BD and healthy controls (Table 1). The
characteristics of the different cells in the stained smears
are detailed in Table 1. In addition, there were larger
numbers of nonkeratinized cells in the parabasal layer of
smears from the aphthous areas of the BD patients. These
cells were smaller than the other cells, but they had a larger
nucleus (41). The cytomorphometric analysis revealed an
increased NV/CV ratio in the aphthous areas of the BD
patients. This will cause nuclei enlargement and change
the NV/CV ratio of patients with BD aphthous areas.
In conclusion, BD patients taking long-term
immunosuppressive drugs exhibit morphological,
apoptotic, and cytomorphometric alterations in their oral
mucosa. These qualitative and quantitative cytological
alterations may reflect the premalignant condition of the
oral cavity.
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